CAP 150 (Capecitabine 150 mg)
Pill with imprint CAP 150 is Pink, Capsule-shape and has been identified as Capecitabine 150 mg. It is supplied by Shilpa Medicare Limited.
Capecitabine is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer; non-small cell lung cancer; pancreatic cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CAP 150
Capecitabine
- Imprint:
- CAP 150
- Strength:
- 150 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antimetabolites
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Shilpa Medicare Limited
- National Drug Code (NDC):
- 63759-3000
More about capecitabine
- Capecitabine Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 26 Reviews
- Drug class: antimetabolites
Consumer resources
Other brands: Xeloda
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
